| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 06/21/2001 | US20010004636 Into a mammalian parenchymal cell, by complexing a polynucleotide with a nonviral vector, amphipathic compounds, or polymer, inserting into a mammalian vessel, increasing the permeability of the vessel; use in gene therapy |
| 06/21/2001 | US20010004458 Rapidly disintegrating pellets |
| 06/21/2001 | US20010004454 Metal complexes derivatized with folate for use in diagnostic and therapeutic applications |
| 06/21/2001 | DE19961256A1 Kosmetische Zubereitungen Cosmetic preparations |
| 06/21/2001 | DE19961182A1 Galactomannan-Oligosaccharide und Verfahren zu deren Herstellung sowie deren Verwendung Galactomannan oligosaccharides and processes for their preparation and their use |
| 06/21/2001 | DE19960917A1 Neue 3-Oxo-2,1-benzisoxazol-1(3H)-carboxamide zur Behandlung von ZNS-Erkrankungen New 3-oxo-2,1-benzisoxazol-1 (3H) -carboxamide for the treatment of CNS disorders |
| 06/21/2001 | DE19960767A1 Production of mildly washing-active cosmetic or dermatological formulation, e.g. shower or bath preparation, cleanser or shampoo, uses cosurfactant to reduce critical micelle formation concentration of washing-active surfactant |
| 06/21/2001 | DE19960105A1 Catecholoxime und ihre Verwendung in kosmetischen und dermatologischen Zubereitungen Catecholoxime and their use in cosmetic and dermatological preparations |
| 06/21/2001 | DE19959697A1 14,15-Cyclopropanosteroide der 19-Norandrostan-Reihe, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende pharmazeutische Zusammensetzungen 14,15-Cyclopropanosteroide the 19-norandrostane series, process for their preparation and pharmaceutical compositions containing them |
| 06/21/2001 | DE19959696A1 Ungesättigte 14,15-Cyclopropano-Androstane, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende pharmazeutische Zusammensetzungen Unsaturated 14,15-cyclopropano-androstanes, to processes for their preparation containing these compounds and pharmaceutical compositions |
| 06/21/2001 | DE19959546A1 Pharmazeutische Zubereitung zur Behandlung von Tumorerkrankungen A pharmaceutical preparation for treatment of tumor diseases |
| 06/21/2001 | DE19959419A1 Stabile galenische Zubereitungen umfassend ein Benzimidazol und Verfahren zu ihrer Herstellung Stable pharmaceutical formulations comprising a benzimidazole and process for their preparation |
| 06/21/2001 | DE19957889A1 New nucleic acid encoding triterpenoid-cyclase, useful for producing cyclic triterpenoids and for increasing content of polyunsaturated fatty acids in transgenic organisms |
| 06/21/2001 | DE19956486A1 Mehrschichtige Zubereitung zur gesteuerten, pulsartigen Abgabe von Wirkstoffen Multi-layer preparation for controlled, pulsatile delivery of active ingredients |
| 06/21/2001 | DE19955190A1 Stabile Salze neuartiger Derivate von 3,3-Diphenylpropylaminen Stable salts of novel derivatives of 3,3-diphenylpropylamines |
| 06/21/2001 | DE19911557A1 Use of levothyroxin for prevention of migraine symptoms |
| 06/21/2001 | CA2551203A1 Novel forms of pravastatin sodium |
| 06/21/2001 | CA2401236A1 Method for the preparation of citalopram |
| 06/21/2001 | CA2397601A1 Novel processes for making- and a new crystalline form of- leflunomide |
| 06/21/2001 | CA2396543A1 Conjugated fatty acids and related compounds, and method for their enzymatic preparation |
| 06/21/2001 | CA2395555A1 Processes for preparing clarithromycin polymorphs and novel polymorph iv |
| 06/21/2001 | CA2395486A1 Saccharin derivatives as orally active elastase inhibitors |
| 06/21/2001 | CA2395474A1 Methods and compositions for the prevention and treatment of atherosclerosis, restenosis and related disorders |
| 06/21/2001 | CA2395289A1 Transdermal administration of phenylpropanolamine |
| 06/21/2001 | CA2395170A1 Anti-cancer agents (iii) |
| 06/21/2001 | CA2395167A1 Novel 3-oxo-2,1-benzisoxazol-1(3h)-carboxamides for treatment of cns diseases |
| 06/21/2001 | CA2395119A1 Use of carboxy compounds such as 2(4-acetoxyphenyl)-2-chloro-n-methyl-ethylammonium chloride as anti-inflammatory agents |
| 06/21/2001 | CA2395088A1 Biphenyl sulfonamides as dual angiotensin endothelin receptor antagonists |
| 06/21/2001 | CA2395075A1 1,3,4-substituted piperidine analogs and uses thereof in treating addictions |
| 06/21/2001 | CA2394767A1 Thienylalanine derivatives as inhibitors of cell adhesion |
| 06/21/2001 | CA2394654A1 Proton pump inhibitors |
| 06/21/2001 | CA2394650A1 Novel heterocycles |
| 06/21/2001 | CA2394646A1 Novel purines |
| 06/21/2001 | CA2394640A1 Galactomannan-oligosaccharides and methods for the production and use thereof |
| 06/21/2001 | CA2394573A1 Purine derivatives |
| 06/21/2001 | CA2394570A1 N-(1-phenylethyl)-5-phenyl-imidazole-2-amine compounds, their compositions and uses |
| 06/21/2001 | CA2394569A1 Pharmaceutical gel and aerosol formulations and methods to administer the same to skin and mucosal surfaces |
| 06/21/2001 | CA2394552A1 N-[5-[[[5-alkyl-2-oxazolyl]methyl]thio]-2-thiazolyl]carboxamideinhibitors of cyclin dependent kinases |
| 06/21/2001 | CA2394548A1 Antipsychotic heterocycle compounds |
| 06/21/2001 | CA2394544A1 N-[5-[[[5-alkyl-2-oxazolyl]methyl]thio]-2-thiazolyl]-carboxamide inhibitors of cyclin dependent kinases |
| 06/21/2001 | CA2394538A1 Aminothiazole inhibitors of cyclin dependent kinases |
| 06/21/2001 | CA2394536A1 Tnfr/opg-like molecules and uses thereof |
| 06/21/2001 | CA2394466A1 Polypeptides and nucleic acids encoding same |
| 06/21/2001 | CA2394464A1 Process for the preparation of sodium salts of statins |
| 06/21/2001 | CA2394416A1 Composition in the form of a gel for receiving an active ingredient in a solution or suspension, especially for application on a mucous membrane and method of production thereof |
| 06/21/2001 | CA2394313A1 Novel lipopeptides as antibacterial agents |
| 06/21/2001 | CA2394211A1 Stabilizers for sodium l-ascorbate-2-phosphate |
| 06/21/2001 | CA2394210A1 Use of retinoid receptor antagonists in the treatment of cartilage and bone pathologies |
| 06/21/2001 | CA2394130A1 Substituted norbornylamino derivatives, method for the production thereof, use thereof as a medicament or a diagnostic reagent and medicaments containing said compounds |
| 06/21/2001 | CA2394077A1 System and method for extended delivery of a therapeutic agent with its receptor loading dose |
| 06/21/2001 | CA2394012A1 Combination of ginseng and ginkgo to improve cognitive skills |
| 06/21/2001 | CA2393972A1 Cyclopenteneone derivatives |
| 06/21/2001 | CA2393838A1 Flat medicinal preparation for transmucosal administration of oxycodon or a comparable active ingredient in the oral cavity, for use in pain therapy and in addiction therapy |
| 06/21/2001 | CA2393825A1 Novel succinate compounds, compositions and methods of use and preparation |
| 06/21/2001 | CA2393808A1 Anti-cancer synthetic oligonucleotides |
| 06/21/2001 | CA2393762A1 Hydroxide-releasing agents as skin permeation enhancers |
| 06/21/2001 | CA2393672A1 Selective neurokinin antagonists |
| 06/21/2001 | CA2393366A1 Improved omeprazole process and compositions thereof |
| 06/21/2001 | CA2393358A1 Heterocycle derivatives and drugs |
| 06/21/2001 | CA2393301A1 Analogs of galanthamine and lycoramine as modulators of nicotinic receptors |
| 06/21/2001 | CA2393255A1 Nutritional composition, methods of producing said composition and methods of using said composition |
| 06/21/2001 | CA2393027A1 Inhibitors of interleukin 5 gene expression |
| 06/21/2001 | CA2392992A1 Imidazopyrimidinyl and imidazopyridinyl derivatives |
| 06/21/2001 | CA2392955A1 Substituted 1,2,3-triazolo[1,5-a]quinazolines for enhancing cognition |
| 06/21/2001 | CA2392953A1 Triazolo-pyrimidine derivatives as ligands for gaba receptors |
| 06/21/2001 | CA2392944A1 Pyrazolo-pyridine derivatives as ligands for gaba receptors |
| 06/21/2001 | CA2392894A1 New p2x7 receptor antagonists for use in the treatment of inflammatory, immune or cardiovascular diseases |
| 06/21/2001 | CA2392766A1 Novel helicobacter pylori-binding substances and use thereof |
| 06/21/2001 | CA2392700A1 Reduced calorie fat compositions |
| 06/21/2001 | CA2391957A1 Pharmaceutical implant containing immediate-release and sustained-release components and method of administration |
| 06/21/2001 | CA2391950A1 Implant composition containing melengestrol acetate and trenbolone acetate |
| 06/21/2001 | CA2391259A1 Composition for improving the proliferative response during adaptation of the gastrointestinal tract and use in short bowel syndrome |
| 06/21/2001 | CA2390821A1 Inhibitors of adenosine kinase for the treatment of optic nerve and retinal damage |
| 06/21/2001 | CA2390689A1 Human lyases and associated proteins |
| 06/21/2001 | CA2390674A1 Antisense oligonucleotides for the inhibition of expression of type i procollagen |
| 06/21/2001 | CA2390662A1 Bcl-g polypeptides, encoding nucleic acids and methods of use |
| 06/21/2001 | CA2387047A1 Benzoic acid esters of oxazolidinones having a hydroxyacetylpiperazine substituent |
| 06/21/2001 | CA2328586A1 Use of 3,3',5,5'-tetrahydroxystilbene as an anti-glycation agent |
| 06/20/2001 | EP1108721A1 Thienylalanine derivatives as inhibitors of cell adhesion |
| 06/20/2001 | EP1108718A2 Trans-6-Acetyl-4S-(4-fluorobenzoylamino)-3,4-dihydro-2,2-dimethyl-2H-1-benzopyran-3R-ol |
| 06/20/2001 | EP1108717A2 C7 taxane derivatives and pharmaceutical compositions containing them |
| 06/20/2001 | EP1108716A2 C7 taxane derivatives and pharmaceutical compositions containing them |
| 06/20/2001 | EP1108436A1 Preventives/remedies for arteriosclerosis and post-ptca reangiostenosis |
| 06/20/2001 | EP1108434A1 Drugs for relieving carbonyl stress and peritoneal dialysates |
| 06/20/2001 | EP1108431A1 Gastroresistant multi-unitary pharmaceutical preparations containing piroxicam |
| 06/20/2001 | EP1108430A1 Calcium channel antagonists |
| 06/20/2001 | EP1108429A2 An improved amino acid composition for providing an amino acid supplement or protein substitute, particularly for the treatment and/or management of certain diseases |
| 06/20/2001 | EP1108428A2 Compositions for and uses thereof for treating viral disease with phenylacetate and derivatives thereof |
| 06/20/2001 | EP1108427A2 Compositions for and uses thereof for altering gene expression with phenylacetate and derivatives thereof |
| 06/20/2001 | EP1108426A2 Use of prostaglandin agonists to treat erectile dysfunction or impotence |
| 06/20/2001 | EP1108425A1 New stable multi-unitary pharmaceutical preparations containing substituted benzimidazoles |
| 06/20/2001 | EP1108424A1 Matrix tablet for sustained release of trimetazidine after oral administration |
| 06/20/2001 | EP1108420A1 Cosmetic formulations |
| 06/20/2001 | EP1108365A2 Encapsulated long chain alcohols |
| 06/20/2001 | EP1108364A2 Long chain alcohols admixed in sterol compounds |
| 06/20/2001 | EP1108095A1 Elephant-nosed toilet plunger |
| 06/20/2001 | EP1108068A1 T-type calcium channel |
| 06/20/2001 | EP1108046A1 Guanylate binding protein (gbp-1) as inhibitor of cell proliferation and molecular marker for the determination of the stage of cellular differentiation |
| 06/20/2001 | EP1108039A2 Elongase genes and uses thereof |
| 06/20/2001 | EP1108038A1 Superoxide dismutase as a vaccine antigen |